Mean BP from initial visit to four years

Slides:

Advertisements

Similar presentations

JNC 8 Guidelines….

Advertisements

For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.

NHANES III Prevalence of Hypertension* According to BMI

HYPERTENSION in ADPKD Sabine Karam M.D.. Introduction  ADPKD is the most common life-threatening single-gene disease  It affects over 12 million people.

Nursing 210 Advanced Cardiac UNIT 2 Laurie Brown RN, MSN, MPA-HA, CCRN.

BLOOD PRESSURE Systolic Diastolic.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.

Hypertension A Case Study Jennifer Kitchen July 19, 2013.

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.

TOMHS 8.3% 6.8% 18.3% 2.8% 6.6% 6.8%. Treatment of Mild Hypertension Study (TOMHS) Eligibility Visits 902 men/women Age years DBP mm Hg Free.

Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.

IS AGE AN INDEPENDENT PREDICTOR OF ADVERSE DRUG EVENTS TO LOOP DIURETICS? UMDNJ - SOM Wunhuey Cheng D.O. Mentored by Anita Chopra M.D. Sherry Pomerantz.

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,

UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)

UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.

VBWG PROactive: Study design Dormandy JA et al. Lancet. 2005;366: Charbonnel B et al. Diabetes Care. 2004;27: Objective: Assess the effects.

Hypertension By: Kenneth Hall and Matt McCallum Matt McCallum.

Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed.

JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.

Wald DS, et al. Am J Med 2009;122: Details of the 42 Trials Included in the Meta-analysis - Part I Wald DS, et al. Am J Med 2009;122:

Saleem Jessani 1, Rasool Bux 1 and Tazeen H. Jafar 1,2. 1 Aga Khan University, Karachi, Pakistan 2 Duke-NUS Graduate Medical School, Singapore Socio-demographic.

Janice Herbert-Carter, MD, MGA, FACP Associate Professor of Medical Education.

Internal Medicine Workshop Series Laos September /October 2009.

Date of download: 9/20/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use of radial artery applanation tonometry and a.

Hypertension guidelines What’s all the controversy about 2015

Health April 13, 2017.

Baseline characteristics and effectiveness results

Copyright © 2015 American Medical Association. All rights reserved.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Drugs for Hypertension

Vanguard Phase Results for the Blood Pressure Component

Elevated Circulating Levels of Inflammatory Markers in

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

Subclinical organ damage Treatment LVH

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

Hypertension: A Risk Factor For Stroke

UNIT 2: ANTIHYPERTENSIVE DRUGS

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.

Creatinine clearance (mL/min) n All-cause mortality (%)

Nat. Rev. Nephrol. doi: /nrneph

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Why double blind, controlled randomized trials?

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Hazard ratios (HR) for ESRD or death for 1-SD increase in systolic BP: Home recording vs clinic measurement BP measurement HR for each 1-SD increase.

End point Net change with soy supplements vs control (95% CI) p

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

William T. Abraham et al. JCHF 2015;3:

RECORD Study: Enrollment and Outcomes

Kaplan-Meier Curves for the Percentages of Subjects with Microalbuminuria during Treatment with Trandolapril plus Verapamil or Placebo Piero Ruggenenti.

Internal Medicine Workshop Series Laos September /October 2009

KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Expected value of perfect implementation: population net health benefit and maximum justifiable investment if all patients who were eligible received beta.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

End point Valsartan Valsartan+HCTZ p

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

(D) Systolic blood pressure (BP) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. . (D) Systolic blood pressure.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Percentage change from baseline in homeostatic model assessment (HOMA) score, vascular endothelial growth factor (VEGF), epidermal growth factor (EGF),

Fig. 3: Possible algorithm for controlling blood pressure in diabetic patients with microalbuminuria. [This algorithm is based on the opinions and practice.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

Mean BP from initial visit to four years Time Systolic BP + SD (mm Hg) Diastolic BP + SD (mm Hg) Initial visit (n=340) 151+27 80+13 4 y (n=70) 135+18 75+11 Thanamayooran S et al. Nephrol Dial Transplant 2005; 20:2385-2393.

Number, type of BP medications from baseline to four years Time point Medications, n ACE inhibitor or ARB (%) Diuretic (%) Beta blocker (%) Calcium-channel blocker (%) Initial visit 2.20 43 49 38 41 2 y 2.41 65 54 4 y 2.63 64 57 58 Thanamayooran S et al. Nephrol Dial Transplant 2005; 20:2385-2393.